BridgeMD
New treatment option for Diabetes Mellitus
Official title Improving Glycemic Control With Telemedicine and Smart Insulin Pens
ClinicalTrials.gov ID: NCT06918977
What this study is testing
- What it's testing
- Almost 40% of veterans have diabetes, the proposed research may improve clinical care among veterans with diabetes. In this application we are going to examine whether utilizing Smart Insulin pens (SIPs) with CGMs and telemedicine is a better tool for managing diabetes compared to traditional insulin pens, CGMs and telemedicine, leading to improved blood sugar control and better clinical outcomes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- ≥18 years of age
- MDI insulin treated (receiving MDI for at least 3 months prior to the study)
You likely can't join if
- DM patients not treated with MDI for at least 3 months (i.e diet only, any combination of non-insulin antidiabetic drugs only, basal insulin only or...
- Patients with DM at the time of screening on insulin pumps
- Pregnant patients
- Patients with extensive skin disease or allergies that preclude wearing the CGM sensor
- Patients who have end-stage renal disease requiring dialysis
- Patients with significant psychiatric illness or any other condition rendering the subject incapable of understanding the objectives and potential...
See the full eligibility criteria
- ≥18 years of age
- MDI insulin treated (receiving MDI for at least 3 months prior to the study)
- DM patients not treated with MDI for at least 3 months (i.e diet only, any combination of non-insulin antidiabetic drugs only, basal insulin only or bolus/short acting insulin only)
- Patients with DM at the time of screening on insulin pumps
- Pregnant patients
- Patients with extensive skin disease or allergies that preclude wearing the CGM sensor
- Patients who have end-stage renal disease requiring dialysis
- Patients with significant psychiatric illness or any other condition rendering the subject incapable of understanding the objectives and potential consequences of the study
- Patients who receive hydroxyurea or who are on long (chronic) treatment with acetaminophen
- Patients who were started on non-insulin DM medications or had a dose change within 60 days or less prior to study participation
- Patient does not have or not able to gain access to a smartphone which is compatible with the necessary applications for DAT
The study team makes the final eligibility decision.
Where it's taking place
- Baltimore, Maryland, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baltimore, Maryland, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.